1936
DOI: 10.1007/bf01779758
|View full text |Cite
|
Sign up to set email alerts
|

Über die Einwirkung des Vitamin C auf das Pathologisch Veränderte Weisse Blutbild

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1938
1938
2009
2009

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(3 citation statements)
references
References 1 publication
0
3
0
Order By: Relevance
“…Eufinger and Gaehtgens 17 , in 1936, reported the successful treatment of myeloid leukemia using vitamin C, and ever since, it is has been receiving attention as substance capable of acting in carcinogenesis prevention. Several epidemiological studies had been performed trying to relate cancer and vitamin C consumption, in the normal diets or as alimentary supplement.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Eufinger and Gaehtgens 17 , in 1936, reported the successful treatment of myeloid leukemia using vitamin C, and ever since, it is has been receiving attention as substance capable of acting in carcinogenesis prevention. Several epidemiological studies had been performed trying to relate cancer and vitamin C consumption, in the normal diets or as alimentary supplement.…”
Section: Discussionmentioning
confidence: 99%
“…Diethylnitrosamine (NDEA), a substance known for more than 30 years due to its capacity of formation of tumors, was used in this study for induction of esophageal cancer 18 , following the Rubio standardization 19 and Sallet et al researches 5,6 . The main mechanism by which the vitamin C may interfere with carcinogenesis is related to its ability in reducing the nitrous acid, preventing the formation of nitrosamines in the stomach 17 .…”
Section: Discussionmentioning
confidence: 99%
“…However, for those interested in designing such a trial, an encouraging background of publications exists, ranging from individual case reports, through anecdotal accounts, to pilot studies involving large numbers of advanced cancer patients (64,68,100,114,129,146,159,164,177,184,214,248,261,283,287,288,289,320,327,330,331,332), all reporting some degree of clinical benefit conferred by supplemental ascorbate. Our own clinical studies, discussed in several publications (51-53, 56-59, 226), strongly indicate that supplemental ascorbate not only increases well-being but also produces a statistically significant increase in the survival times of advanced cancer patients.…”
Section: Other Relevant Effects Of Ascorbic Acidmentioning
confidence: 99%